![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_1a916b499f81cc02e6eac8952a0b9b9b.svg) | 6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine | IC50 | 250.0 [1], 333.0 [2], 3000.0 [3], 10000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_613bd559e314252ec76ed0cdf79b77e9.svg) | 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | IC50 | 2000.0 [1], 7340.0 [2], 7440.0 [3], 32820.0 [4] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f62bceea3e4b8aea8dc74665920b5706.svg) | 3-Cyano-4-[2-(2-methylpyrazol-3-yl)phenoxy]-N-(1,3-thiazol-2-yl)benzenesulfonamide | IC50 | 10000.0 [1], 30000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_0479fa9659f7f43e5e6dd582a326bbb6.svg) | [3-(Dimethylamino)-4-methoxyphenyl]-(7-methoxyspiro[5H-pyrrolo[1,2-a]quinoxaline-4,4'-piperidine]-1'-yl)methanone | IC50 | 351.0 [1], 572.0 [2], 10485.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_8889ba945b627a40a411d2b142f7e056.svg) | 4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamide | IC50 | 16000.0 [1], 30000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_bddc1e60f949fb6d7be74ac568302dec.svg) | 5-Chloro-2-fluoro-4-[(4-hydroxycyclohexyl)methylamino]-N-(1,3-thiazol-2-yl)benzenesulfonamide | IC50 | 156.0 [1], 380.0 [2], 730.0 [3], 1300.0 [4] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_25b86e6872de5faf9c66524e9a51a6ca.svg) | 2-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one | IC50 | 1330.0 [1], 1900.0 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d807cd36eea3bdcc2c2c3e9b5d13b932.svg) | Lamotrigine | IC50 | 39810.72 [1], 62000.0 [2], 100000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_c7416e1543ca26168b769dc25d1f2310.svg) | Tetracaine | IC50 | 200.0 [1], 530.0 [2], 650.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_89fd1058473b46f547fd6ef0c68156d1.svg) | Propafenone | IC50 | 1190.0 [1], 3300.0 [2], 5000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d2b3ff02222ead77c6247d4c5637b79b.svg) | Mexiletine | IC50 | 13000.0 [1], 58000.0 [2], 420000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_01451c73b9c1f68aac3778db2f20814c.svg) | Dofetilide | IC50 | 300000.0 [1], 316227.77 [2], 630957.34 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_55892479c77cb8cbec69941708da1cce.svg) | CID 46840946 | IC50 | 11.0 [1], 10000.0 [2], 25000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d33ec2b41b84fafe803d97bde6190274.svg) | N-[2-Methyl-3-[[4-[4-[[4-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]-1,3,5-triazin-2-yl]amino]phenyl]acetamide | IC50 | 1100.0 [1], 5200.0 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_a85e3f1b234291e74e02c280b4cfe59a.svg) | Nav1.7-IN-3 | IC50 | 2.2 [1], 30000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_0b83c38cc47733eab66fd9a3b08ba037.svg) | CID 118734430 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_a7042af93f48de5602abfcad6228e60c.svg) | CID 118734436 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d7a6c6c63336796a1f88eb69a251aeb8.svg) | CID 118734482 | IC50 | 400.0 [1], 2300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_c19e65badd65749de8716c8f448c5d5a.svg) | CID 118734547 | IC50 | 5000.0 [1], 8800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_05d1a1d7e29fb9a8f5aa677df72d67cd.svg) | 4-(1-Adamantylmethoxy)-5-chloro-2-fluoro-N-methylsulfonylbenzamide | IC50 | 1070.0 [1], 1900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f550846401975907c84b2ac0fbbf52b3.svg) | 4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)-2,3-dihydro-1,4-benzoxazine-7-sulfonamide | IC50 | 1990.0 [1], 2000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_0affb3943f205dc2579bb8294674f97b.svg) | 2-N-[4-(4-Chlorophenoxy)phenyl]-1,3,5-triazine-2,4-diamine | IC50 | 200.0 [1], 3200.0 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_8716d1379fc9fcdaef8beabc3dd79da1.svg) | N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide | IC50 | 19000.0 [1], 69000.0 [2], 100000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f51b049765c4fb65e756372294890310.svg) | N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide | IC50 | 920.0 [1], 14800.0 [2], 36000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_cf880db41d043c5aadc39c88ebaa79b1.svg) | 2-N-[4-[4-(Trifluoromethoxy)phenoxy]phenyl]pyrazine-2,6-diamine | IC50 | 1260.0 [1], 1500.0 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_444fa0db37706d6efa6c25fb3dd7c1de.svg) | Phenytoin | IC50 | 49000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_ce2451a6dd9c86e3ec85025ead605266.svg) | Sildenafil | IC50 | 501187.23 [1], 1258925.41 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d9d88c2a7bdabc45b702c06047b28bae.svg) | Quinidine | IC50 | 6900.0 [1], 16600.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_95b92c7a51ad4bb33df4aec269cfa5fa.svg) | Moxifloxacin | IC50 | 39810.72 [1], 251188.64 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_b3aa0f2927a093dd9ba4f0c5486d3682.svg) | Everolimus | IC50 | 199526.23 [1], 630957.34 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_7de5848be93196a6906eba944a298431.svg) | Sunitinib | IC50 | 15848.93 [1], 39810.72 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_986db0437f20070dfb14143a9f1b018d.svg) | Dasatinib | IC50 | 100000.0 [1], 398107.17 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_b429be022623e6dba89dbd55075672bf.svg) | Duloxetine | IC50 | 7943.28 [1], 15848.93 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_601c33238027d88f839c5e4fc21f3344.svg) | Nelfinavir | IC50 | 79432.82 [1], 501187.23 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_4a2f7aa95b8e5fa8d1122874409c701a.svg) | Tadalafil | IC50 | 125892.54 [1], 158489.32 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_b22ee7becceb5ad9c31ec4529677de35.svg) | Sitagliptin | IC50 | 630957.34 [1], 794328.23 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f59214b920b0faf58103b7de887f46c7.svg) | Nilotinib | IC50 | 1000000.0 [1], 5011872.34 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_be593ec210e611853ecfa367c8ba0022.svg) | Raltegravir | IC50 | 316227.77 [1], 1584893.19 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_47f0bc6989009707a0e42006229bb2b9.svg) | Darunavir | IC50 | 39810.72 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_611aee8360ba5f29cd9711190dfe1482.svg) | Vardenafil | IC50 | 199526.23 [1], 2511886.43 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_e062b395a3ae7be9147860ab78c92beb.svg) | Tolterodine | IC50 | 6309.57 [1], 31622.78 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_8ae9092a1acc8d5031d0a55ff520619e.svg) | Nebivolol | IC50 | 6309.57 [1], 7943.28 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f1e44219327ec5d3833ac42aff528e73.svg) | Maraviroc | IC50 | 630957.34 [1], 1000000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_0e03e9bd3ca5182dc5be5efc63b439c2.svg) | Deferasirox | IC50 | 79432.82 [1], 501187.23 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_e8bd31cd17a67cd8d7da95b1194a4650.svg) | Paliperidone | IC50 | 25118.86 [1], 158489.32 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_90640a95cbf3e6e2ddfa56dd14c8f9c7.svg) | Etravirine | IC50 | 501187.23 [1], 3981071.71 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_be653f89bf9757f77ea6b06dba105b92.svg) | Alfuzosin | IC50 | 199526.23 [1], 1584893.19 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_99974635fe8d76f26549fd768a4d73f4.svg) | Eltrombopag | IC50 | 158489.32 [1], 316227.77 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_6abe2f67827e0a50fdfd56dd09f893a8.svg) | Ambrisentan | IC50 | 1000000.0 [1], 1258925.41 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_e16c8e9bb75059a5a2d9fc04b5ff4ebf.svg) | Desvenlafaxine | IC50 | 199526.23 [1], 316227.77 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_a7a3e6c074f97d267148d315bdd54aa0.svg) | Oliceridine | IC50 | 4700.0 [1], 16500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_172c8df189717c094e406d20e6ddc268.svg) | F-15845 Free base | IC50 | 2560.0 [1], 5770.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_9846ce0321457de0f9cee8c28fc15bdb.svg) | 3-(2-Aminopropoxy)-2,4-dimethylphenol | IC50 | 30000.0 [1], 174000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_a462c0bfa1d0e2a99d0468fe87ed726c.svg) | Auglurant | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_25d9b33026565fc9b2cb6059f4773987.svg) | 2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide | IC50 | 9200.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f5527955ab94658607e86abaefac62c1.svg) | (2S)-2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-27,57-bis(4-aminobutyl)-21-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-24-(3-amino-3-oxopropyl)-54,74-bis(3-carbamimidamidopropyl)-13,51-bis(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36,68-tris(1H-indol-3-ylmethyl)-71-(2-methylpropyl)-7,33-bis(2-methylsulfanylethyl)-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-4-propan-2-yl-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosazatricyclo[40.34.4.216,60]dooctacontane-65-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | IC50 | 79.0 [1], 90.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_99f04051f3a3c2e2d86079a90b1965c9.svg) | 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]acetamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_0655a0f80832be04b0950c13a7240f1c.svg) | 1-[2-Methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-2-oxo-N-pyrimidin-2-ylquinoline-6-sulfonamide | IC50 | 30000.0 [1], 42500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_509904b76d88e4424d9cca9e7ccf2eca.svg) | 4-[[(3S,4R)-4-(4-Chlorophenyl)piperidin-3-yl]methoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_36e30dd7848e5b7b0d71b036645ac9d6.svg) | CID 118734434 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_b47baa6e721474816a5f5efff79246de.svg) | CID 118734437 | IC50 | 27000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_99bfc707e6d16fee3fe95f0d96c1aba0.svg) | CID 118734438 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_a98439adb7fc8c96334f939c33cae688.svg) | CID 118734439 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_e59f08ea6e8f06a8f5eb8d597f4a00cc.svg) | CID 118734440 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_39b9d462f33832b1cca33146b2cf5531.svg) | CID 118734441 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_2a7d8a8aa1761f7fe79b14144aa8533b.svg) | CID 118734442 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_7cce33bfe8f3391553d0f13b8e3a1fcd.svg) | CID 118734443 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_508cad3a32c4d7b8fcff0a432e3dc429.svg) | CID 118734444 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_5a18223e7a13523281c2bc8fa1e7581b.svg) | CID 118734445 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_95324868a621800059c1b5796805f426.svg) | CID 118734446 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_e6f67e3b4f1b0f6a5ae5f0bd0768aec3.svg) | CID 118734447 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_f735408d0b022dff4081dde9a3d97163.svg) | CID 118734448 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d144463a38a932dd2f40d7b1357746a0.svg) | CID 118734449 | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_5e0e99bc265f7ad1af246bd787dbb836.svg) | CID 118734450 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_2ef35478f88f2a1134d0b0a40adad68c.svg) | CID 118734451 | IC50 | 4700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_7cba5000fa1014b1241c2fa7d677151c.svg) | CID 118734452 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_777255eb7e3751e75a76545ffd44ac5e.svg) | CID 118734456 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_95c1d0768b869d42ee9e2a803b5823bc.svg) | CID 118734458 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_7d16533307b39dd0ea815274f6727abb.svg) | CID 118734459 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_1ebeccec9ef6a0f01e97e5a0712d2e14.svg) | CID 118734460 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_8d1b8ff55041dd5a5f529cb3fdbd30e4.svg) | CID 118734461 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_2933fc733fd62f20c8d097d58a5fc7d8.svg) | CID 118734489 | IC50 | 500.0 [1], 3500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_d64b8fe6e212292bdfdf16b4d0c1c805.svg) | CID 118734490 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_5fc6e7b062805460341cbdbaef5401e5.svg) | CID 118734548 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_b60a7948c06fbea02fce675c03012c67.svg) | 1-[2-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropoxy]-5-fluorophenyl]-3-phenylpropan-1-one | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_084edc4c539d6ff7d1ccb367bd3eb665.svg) | 1-[2-[2-Hydroxy-3-[4-(4-methylphenyl)piperazin-1-yl]propoxy]phenyl]-3-phenylpropan-1-one | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_db1804d43d3a61a6d4f2abae2ca9fe79.svg) | Unii-403N302X2Y | IC50 | 12589.25 [1], 13000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_5d76064ddc2dff8b46597ab1ba156fa1.svg) | (6S)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole-6-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_89127fb022eff949e2e5b8b2d69f16b1.svg) | 1-Methyl-3-[2-(2-methylpyrazol-3-yl)-4-(trifluoromethyl)phenyl]-N-(1,2,4-thiadiazol-5-yl)indole-6-sulfonamide | IC50 | 10000.0 [1], 30000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_de119abfff9f20abb9a096724bb462f5.svg) | 4-[2-(2-Amino-3H-benzimidazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_c845d6dbbed4ea254b11f7c86ac18aaa.svg) | 4-[2-(3-Amino-1,2-benzoxazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 1000.0 [1], 1380.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_722c621ffb02e379ed12b3dedfac01e8.svg) | (4R)-N-[4-[[(2S,5R)-5-[(R)-Hydroxy(pyridin-3-yl)methyl]pyrrolidin-2-yl]methyl]phenyl]-5,6-dihydro-4H-cyclopenta[d][1,3]thiazole-4-carboxamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_15c98b90510aa98184a5de8633598a6c.svg) | Tert-butyl 2-amino-4-[3-(1H-indole-2-carbonylamino)phenyl]imidazole-1-carboxylate | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_ba3d0dbddcb0669e9014f069801a24f3.svg) | 3-Cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | IC50 | 2000.0 [1], 12797.25 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_1221cd30884884c1671d23835f294985.svg) | 1-[2-Methoxy-4-(trifluoromethyl)phenyl]-2-oxo-N-(1,3-thiazol-2-yl)quinoline-6-sulfonamide | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_333eb9cb852219be83b99b71423ed8ea.svg) | CID 127045799 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_43122cb696bb4af23e0a0c1e59d75ff7.svg) | CID 127045811 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_6bfe9cd8014c0619f32cb5ae71e872b1.svg) | CID 127046243 | IC50 | 5000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_a58a20351b37e321d98c05435e2cb3d8.svg) | CID 127046252 | IC50 | 5000.0 [1], 15900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/sodium-channel-protein-type-v-alpha-subunit_3626d0d79ba6e48926c631da640aa110.svg) | CID 127046253 | IC50 | 1000.0 [1], 3500.0 [2] |